Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02384434 · ClinicalTrials.gov registry record · NA
Low Level Laser Therapy for Radiation Induced Dermatitis in H & N Squamous Cell Carcinoma
A NA study, sponsored by Heath Skinner.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT02384434: Completed NA study, sponsored by Heath Skinner.
NCT02384434 is a NA study that has completed, run by Heath Skinner. The registered enrollment target is 16 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02384434, a NA study, has completed, sponsored by Heath Skinner.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
This study will assess the efficacy of LLLT to mitigate and ameliorate the acneiform-rash, radiation dermatitis, and pain, while assessing its impact on patient reported quality of life.
Primary Outcome
Number of patients with documented Grade 3 or higher Adverse Events as per CTCAE v4.0.
Interventions
- DEVICE THOR Laser System for Low Level Laser Therapy (LLLT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2015-04-27 |
| Est. Completion | 2020-10-13 |
| Phase | NA |
What the finished NCT02384434 record still lists
NCT02384434 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which THOR Laser System for Low Level Laser Therapy (LLLT) is the first listed.
NCT02384434 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02384434 about?
NCT02384434 is a clinical study titled "Low Level Laser Therapy for Radiation Induced Dermatitis in H & N Squamous Cell Carcinoma". This study will assess the efficacy of LLLT to mitigate and ameliorate the acneiform-rash, radiation dermatitis, and pain, while assessing its impact on patient reported quality of life.
What is the current status of trial NCT02384434?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2015-04-27. Estimated completion is 2020-10-13.
What interventions are being tested in trial NCT02384434?
The interventions under investigation include: THOR Laser System for Low Level Laser Therapy (LLLT) (DEVICE).
Who is sponsoring clinical trial NCT02384434?
This trial is sponsored by Heath Skinner, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02384434's enrollment target sits among peer trials
16 1871st of 2000 higher than 120 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI